Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Stevanato Group ( (STVN) ) is now available.
Stevanato Group has filed an unaudited interim report on Form 6-K for the three months ended March 31, 2026, providing condensed consolidated financial statements and management’s discussion of its financial condition and results. The filing, presented primarily in euros, also outlines risk factors, market risk disclosures, legal proceedings and details on controls, procedures and other statutory reporting items.
The company devotes substantial space to cautionary statements about forward-looking information, flagging numerous operational, geopolitical, regulatory, supply chain and competitive risks that could materially affect future performance. This emphasis underlines the sensitivity of its healthcare-focused manufacturing business to global macroeconomic conditions, trade policy shifts, energy and material costs, and sector-specific dynamics such as post-pandemic destocking of injectable packaging.
The most recent analyst rating on (STVN) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Stevanato Group stock, see the STVN Stock Forecast page.
Spark’s Take on STVN Stock
According to Spark, TipRanks’ AI Analyst, STVN is a Neutral.
The score is anchored by solid financial stability but tempered by weaker cash flow consistency. A positive earnings-call outlook and guidance support the outlook, while bearish technicals and a relatively high P/E weigh on near-term attractiveness.
To see Spark’s full report on STVN stock, click here.
More about Stevanato Group
Stevanato Group S.p.A. is an Italy-based provider of containment, drug delivery and diagnostic solutions for the pharmaceutical and biotech industries. The company designs and manufactures complex primary packaging, such as vials and other components, and supports global healthcare customers with a broad industrial and geographic footprint focused on regulated markets.
Average Trading Volume: 611,999
Technical Sentiment Signal: Hold
Current Market Cap: $5.19B
See more insights into STVN stock on TipRanks’ Stock Analysis page.